Mount Sinai Brooklyn Awarded Advanced Primary Stroke Center Certification From The Joint Commission
Mount Sinai Brooklyn has earned The Joint Commission’s Gold Seal of Approval ® and the American Stroke Association’s Heart-Check mark for Advanced Primary Stroke Center Certification. The hospital achieved this certification by meeting rigorous standards for achieving long-term success in improving outcomes for stroke patients.
Mount Sinai Brooklyn underwent a thorough onsite review by an experienced reviewer from The Joint Commission, a global driver of quality improvement and patient safety in health care. During the visit, the reviewer evaluated compliance with related certification standards, including timeliness of stroke treatment, compliance with established stroke care guidelines, and stroke center organization and protocols. The Joint Commission standards are developed in consultation with health care experts and providers, measurement experts, and patients. The reviewers also conducted on-site observations and interviews.
“This Primary Stroke Center Certification by The Joint Commission is a reflection of the outstanding commitment that our dedicated teams here at Mount Sinai Brooklyn have made to provide the highest safety and quality of care to the stroke patients who turn to us for help,” said Scott Lorin, MD, President of Mount Sinai Brooklyn.
The Mount Sinai Brooklyn Stroke Center has been a leader within the Mount Sinai Health System, being early adopters of new technology and treatments for stroke. Mount Sinai Brooklyn was among the first hospitals within the health system to use artificial intelligence to evaluate CT scans in stroke patients and to use telemedicine for emergency evaluation of stroke treatments, and the first in the system to treat patients with tenecteplase, an emerging innovation in stroke treatment. Mount Sinai Brooklyn also has an experienced team equipped to perform thrombectomy, a minimally invasive procedure that involves removing the clot and quickly restoring blood flow to the brain. During a thrombectomy, a highly specialized neuroendovascular surgeon threads a catheter through an artery in the groin or wrist to the patient’s brain and uses suction and/or a stent to remove the clot.
“We have come a long way in a relatively short period of time in developing the highest standards of care for stroke patients, from the moment of arrival to discharge,” said Steven Rudolph, MD, Director of the Stroke Center and Chief of Neurology at Mount Sinai Brooklyn. “We have established a wonderful spirit of teamwork and collaboration as we continue to enhance our services.”
Mount Sinai Brooklyn is in the process of installing a new generation of magnetic resonance imaging that will allow the treatment of a wider range of stroke patients and speed diagnosis. This device uses artificial intelligence-based software to enhance the quality of images.
About the Mount Sinai Health System
Mount Sinai Health System is one of the nation’s leading integrated academic health systems and one of the largest in the New York metropolitan area. Its comprehensive system includes seven hospitals, more than 400 outpatient practices, over 600 research and clinical laboratories, the Icahn School of Medicine at Mount Sinai, the Graduate School of Biomedical Sciences, and the Mount Sinai Phillips School of Nursing. Together, the Health System comprises approximately 48,000 employees, more than 9,000 physicians, and 8,600 nurses.
As a leading learning health system, Mount Sinai combines clinical expertise with scientific discovery to improve patient care while training the next generation of health care and biomedical leaders. The Health System provides care across every stage of life, from prenatal care through geriatrics, while advancing personalized medicine through artificial intelligence, data science, and biomedical research.
Mount Sinai is consistently recognized among the nation’s leading academic health systems for patient care, research, and education. The Mount Sinai Hospital is ranked No. 1 in New York by Newsweek and No. 5 on the magazine’s World’s Best Hospitals list. The Icahn School of Medicine at Mount Sinai ranks No. 11 among U.S. medical schools and No. 1 among freestanding medical schools for National Institutes of Health funding, reflecting the strength of its scientific enterprise and leadership in biomedical research.